Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Sanofi-Aventis S.A. (SNY)

40.66 -0.3 (-0.73%)

04-18 16:02

Open:

40.94

Pre. Close:

40.96

High:

40.96

Low:

40.55

Volume:

2,586,912

Market Cap:

101384M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

41.008 - 41.224

41.224 - 41.408

Low:

40.031 - 40.279

40.279 - 40.49

Close:

40.255 - 40.674

40.674 - 41.03

Technical analysis  (as of: 2018-04-18 4:44:28 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 48.47     One year: 56.62

Support:

Support1: 40.05    Support2: 39.15

Resistance:

Resistance1: 41.50    Resistance2: 48.47

Pivot:

40.41

Moving Averages:

MA(5): 40.77     MA(20): 40.20

MA(100): 42.06     MA(250): 45.77

MACD:

MACD(12,26): 0.14     Signal(12,26,9): 0.04

%K %D:

%K(14,3): 69.09     %D(3): 68.36

RSI:

RSI(14): 52.49

52-Week:

High: 50.65  Low: 38.14  Change(%): -9.2

Average Vol(K):

3-Month: 177107  10-Days 111445

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
SNY has closed below upper band by 37.4%. Bollinger Bands are 31.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-04-18T17:49:43-04:00
ASLAN Pharmaceuticals Updates U.S. IPO Plans

2018-04-18T15:41:37-04:00
Catalyst Pipeline Portfolio Updates - Strong Start To For The Portfolio

2018-04-17T15:37:55-04:00
Evelo Biosciences Files For U.S. IPO

2018-04-17T06:59:02-04:00
Wall Street Breakfast: Tax Day At The Supreme Court

2018-04-17T06:05:49-04:00
Fixing Drug Costs

2018-04-17T04:22:47-04:00
Sanofi to sell generics arm for Euro1.9B

2018-04-15T00:25:16-04:00
Portfolio Review: Continued Market Outperformance In Q1 2018

2018-04-13T12:40:16-04:00
The Battle For Ampio Pharmaceuticals Reaches Inflection Point As Shorts Run Out Of Gas

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

2492.09

Shares Float (M)

2492.09

% Held by Insiders

% Held by Institutions

8.90

Shares Short (K)

1942

Shares Short Prior Month (K)

1950

Stock Financials

EPS

3.120

EPS Est. Current Year

3.320

EPS Est. Next Year

3.470

EPS Est. Next Quarter

0.800

Forward EPS

3.570

Book Value (p.s.)

1.420

PEG Ratio

2.26

Profit Margin

27.23

Operating Margin

20.35

Return on Assets (ttm)

8.8

Return on Equity (ttm)

15.5

Qtrly Rev. Growth

-2.1

Gross Profit (p.s.)

11.306

Sales Per Share

EBITDA (p.s.)

3.573

Qtrly Earnings Growth

-83.70

Operating Cash Flow (M)

9070.00

Levered Free Cash Flow (M)

13510.00

atoplab.com

Valuation

P/E

13.03

P/E Growth Ratio

-0.01

P/BV

28.63

P/S

2892806144.00

P/CF

11.17

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2018-06-04

Ex-Dividend Date

2017-05-11

Forward Dividend

1.640

Last Split Date

2013-09-30

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.